Download pdf
The Treatment of Cardiovascular Disease
- 1 Beijing New Oriental Yangzhou Foreign Language School, Yangzhou, Jiangsu, China
* Author to whom correspondence should be addressed.
Abstract
With the public's attention to public health and disease prevention and treatment, cardiovascular disease has gradually entered people's vision, and its treatment and prevention have become a topic of great concern in today's society. Cardiovascular disease is the leading cause of death in the world. There are many classification methods for cardiovascular diseases. This article mainly introduce cardiovascular diseases from the etiological classification. And cardiovascular diseases can seriously affect People’s Daily life. Most cardiovascular diseases can be divided into two main groups according to their causative factors: congenital heart disease and acquired heart disease. This article will discuss the causes, treatment, prevention and control of two specific diseases (ventricular septal injury and coronary heart disease) in detail. For the ventricular septal injury, the main treatment is transthoracic closure surgery .For the coronary heart disease, the main treatment is Medical treatment and surgical treatment. Finally, the principles and limitations of each treatment for these two cardiovascular diseases are discussed and summarized. For medication, some medications can cause serious side effects such as dizziness, nausea and rash; Some patients may develop drug resistance after long-term drug treatment; The effectiveness of drug therapy varies from person to person due to differences in individual constitution and metabolic capacity. For surgical treatment, the main limitations are the limitation of indications, high requirements of surgical techniques, and difficult control of surgical risks.
Keywords
Cardiovascular disease, Coronary heart disease, ventricular septal defect, drug therapy, surgical treatment
[1]. Powell-Wiley, T. M., Baumer, Y., Baah, F. O., Baez, A. S., Farmer, N., Mahlobo, C. T., Pita, M. A., Potharaju, K. A., Tamura, K., & Wallen, G. R. (2022). Social Determinants of Cardiovascular Disease. Circulation research, 130(5), 782–799. https://doi.org/10.1161/CIRCRESAHA.121.319811.
[2]. Zhao D. (2021). Epidemiological Features of Cardiovascular Disease in Asia. JACC. Asia, 1(1), 1–13. https://doi.org/10.1016/j.jacasi.2021.04.007.
[3]. Qiao J J, Zhao W Z, Wen B & Xu H S. (2015). Application of transthoracic minimally invasive closure of ventricular septal defects in children. Journal of zhengzhou university (medical edition) (02) 294-296. doi: 10.13705 / j.i SSN. 1671-6825.2015.02.041.
[4]. Turner, M. E., Bouhout, I., Petit, C. J., & Kalfa, D. (2022). Transcatheter Closure of Atrial and Ventricular Septal Defects: JACC Focus Seminar. Journal of the American College of Cardiology, 79(22), 2247–2258. https://doi.org/10.1016/j.jacc.2021.08.082.
[5]. Li Na.(2021). Clinical effect of transthoracic closure of ventricular septal defect and multivariate analysis of influencing factors on hospitalization costs of patients (Master's Thesis, Lanzhou University). Master of https://link.cnki.net/doi/10.27204/d.cnki.glzhu.2021.003088doi:10.27204/d.cnki.glzhu.2021.003088.
[6]. Zhou, Y., Liu, L. X., Zhao, F., Tang, S. H., Peng, H. L., & Jiang, Y. H. (2017). Effects of transthoracic device closure on ventricular septal defects and reasons for conversion to open-heart surgery: A meta-analysis. Scientific reports, 7(1), 12219. https://doi.org/10.1038/s41598-017-12500-6.
[7]. Poulter N. (1999). Coronary heart disease is a multifactorial disease. American journal of hypertension, 12(10 Pt 2), 92S–95S. https://doi.org/10.1016/s0895-7061(99)00163-6.
[8]. Hankey, G. J., & Eikelboom, J. W. (2003). Antiplatelet drugs. The Medical journal of Australia, 178(11), 568–574. https://doi.org/10.5694/j.1326-5377.2003.tb05361.x.
[9]. Violi, F., Calvieri, C., Ferro, D., & Pignatelli, P. (2013). Statins as antithrombotic drugs. Circulation, 127(2), 251–257. https://doi.org/10.1161/CIRCULATIONAHA.112.145334.
[10]. Michaels, A. D., & Chatterjee, K. (2002). Cardiology patient pages. Angioplasty versus bypass surgery for coronary artery disease. Circulation, 106(23), e187–e190. https://doi.org/10.1161/01.cir.0000044747.37349.64.
Cite this article
Li,X. (2024). The Treatment of Cardiovascular Disease. Theoretical and Natural Science,74,144-150.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of ICBioMed 2024 Workshop: Computational Proteomics in Drug Discovery and Development from Medicinal Plants
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).